Homology Medicines Inc. (NASDAQ: FIXX) stock closed at 6.81 per share at the end of the most recent trading day (a -3.13% change compared to the prior day closing price) with a volume of 910.04K shares and market capitalization of 327.16M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 206 people. Homology Medicines Inc. CEO is Arthur O. Tzianabos.

The one-year performance of Homology Medicines Inc. stock is -51.49%, while year-to-date (YTD) performance is -39.68%. FIXX stock has a five-year performance of %. Its 52-week range is between 6.47 and 17.34, which gives FIXX stock a 52-week price range ratio of 0.09%

Homology Medicines Inc. currently has a PE ratio of -2.70, a price-to-book (PB) ratio of 1.93, a price-to-sale (PS) ratio of 171.24, a price to cashflow ratio of 57.40, a PEG ratio of 2.32, a ROA of -42.77%, a ROC of -54.78% and a ROE of -53.91%. The company’s profit margin is -%, its EBITDA margin is -5 181.30%, and its revenue ttm is $2.11 Million , which makes it $0.04 revenue per share.

Of the last four earnings reports from Homology Medicines Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.65 for the next earnings report. Homology Medicines Inc.’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Homology Medicines Inc. is Strong Buy (1.2), with a target price of $26.33, which is +304.46% compared to the current price. The earnings rating for Homology Medicines Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Homology Medicines Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Homology Medicines Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 19.79, ATR14 : 0.72, CCI20 : -106.41, Chaikin Money Flow : -0.29, MACD : -1.45, Money Flow Index : 14.45, ROC : -26.62, RSI : 31.95, STOCH (14,3) : 7.65, STOCH RSI : 0.58, UO : 39.63, Williams %R : -92.35), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Homology Medicines Inc. in the last 12-months were: Albert Seymour (Sold 25 000 shares of value $295 287 ), Kush M. Parmar (Sold 1 000 000 shares of value $12 535 914 ), Timothy P. Kelly (Option Excercise at a value of $49 683), Timothy P. Kelly (Sold 11 768 shares of value $147 323 ), W. Bradford Smith (Option Excercise at a value of $8 640), W. Bradford Smith (Sold 13 500 shares of value $192 425 )